We also looked for differential expression of the candidate danger molecules Annexin A1 and CEACAM1 and saw, consistent with our cell line data, increased Annexin A1 and CEACAM1 expression beginning at the DCIS (MCFT1-like) stage and continuing in invasive cancer. Here, CEACAM1 is linked to ductal breast carcinoma in situ.